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Cholesterol is a core component of the central nervous system, essential for the cell membrane stability and the correct functioning
of neurotransmission. It has been observed that cholesterol may be somewhat associated with suicidal behaviours. Therefore, the
aim of this paper was to elucidate current facts and views about the role of cholesterol levels in mood disorders. The majority
of the studies reviewed in the present paper suggest an interesting relationship between cholesterol (especially lower levels) and
suicidality. On the other hand, particularly during the last years, relationships between serum cholesterol and suicidality were
doubted on the basis of some recent studies that have not found any correlation. However, the debate on relationships between
cholesterol and suicide is open and longitudinal studies on a larger sample of patients are needed to further clarify this important
issue.
1. Introduction
Cholesterol is a core component of the central nervous
system (CNS), essential for the cell membrane stability and
the correct functioning of neurotransmission [1]. It plays a
crucial role in the second messenger systems of the brain that
have been associated with themechanism of action of antide-
pressant drugs and mood stabilizers and may be involved in
the aetiology and pathogenesis of mood disorders [2, 3]. Sev-
eral studies have shown that patients with major depression
(MD) have lower total cholesterol (TC) levels than nonde-
pressed individuals [4, 5]. In addition, lower high-density
lipoprotein (HDL-C) cholesterol concentrations and higher
ratios of TC/high-density lipoprotein (TC/HDL-C) and low-
density lipoprotein/high-density lipoprotein (LDL-C/HDL-
C) are also noted in patients with MD [6–8]. It has been
observed that cholesterol may be somewhat associated with
suicidal behaviours [9, 10]. Moreover, it was found that
adiposity together with a high waist-to-hip ratio may be
associated with an increased risk of suicide [11].
All considered, a possible usefulness in evaluating serum
cholesterol levels in aﬀective patients may be the prediction
of development of suicidal ideation [12]. Therefore, the
monitoring of cholesterol may result in a reduction of
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mortality due to suicidality [9]. However, during the last two
years, involvement of serum cholesterol in pathogenesis of
MD was doubted on the basis of some recent studies that
have not found any correlation between serum cholesterol
and depressive symptoms [13].
Therefore, the aim of the present paper was to elucidate
current facts and views about the role of cholesterol levels in
suicidality.
2. Studies That Found an Association between
Cholesterol and Suicidality
Despite the controversial results about relationships between
cholesterol levels and depressed mood, the majority of the
literature on this subject seems to show a consistent relation-
ship between cholesterol and suicide [14–20]. The possible
relationships between cholesterol levels and suicidality were
initially suggested when an excess mortality for violence
(suicides and injuries) was observed following the use of
cholesterol-lowering drugs [21, 22]. However, even if a meta-
analysis conducted byMuldoon et al. [23] showed that deaths
from suicides, accident, and violence were not significantly
increased among participants randomised to a cholesterol-
lowering intervention compared with those in the control
groups, researchers’ attention was focused on this topic.
Despite some lines of evidence of a link between higher
cholesterol levels and increased suicidality [11, 24], mainly,
as well as for MD, a relationship was found between lower
serum cholesterol levels and suicidality [25–27] especially
in male gender [28]. Gallerani et al. [29] published data
from a controlled population of 331 parasuicides and found
a lower cholesterol level in this group. Sullivan et al. [27]
investigated the association between TC and suicidality in
a sample of 90 men and women with MD and found
a significant association between lower cholesterol levels
and increased suicidality. These findings were confirmed
by Kunugi et al. [30] who similarly found a relationship
between low serum cholesterol and suicide attempts and
by Papassotiropoulos et al. [31] who reported that the
risk of acute suicidality decreased with increasing TC levels
irrespective of age, gender, and nutritional status. Rabe-
Jabłon´ka and Poprawska [32] determined the level of TC and
LDL-cholesterol in blood samples taken from 102 patients
with recurrent major depression (according to Diagnostic
and Static Manual of Mental Disorders, 4th Edition, DSM-
IV) and performed analyses during the acute period of
major depression in 3 subgroups: with and without suicidal
ideation (S+, S−), and after suicidal attempts (AS), and
during remission of depressive symptoms. Moreover, it has
been demonstrated that, in acutely depressed patients, low
TC and LDL-cholesterol were significantly associated with
higher suicide risk. Recently, Olie´ et al. [33] tested the
clinical applicability of a potential cut-oﬀ value in the
evaluation of suicidal risk. They found that the risk of suicide
attempts increased 7.33-fold in men and 15.6-fold in women
in the lowest cholesterol quartile compared to subjects in
the highest quartile. Thus, serum cholesterol level may be
a strong risk factor for suicidal behavior in patients with
depressive symptoms. The authors suggested that total serum
cholesterol levels measured at admission may be a use-
ful biological marker of suicidal risk. Also Ruljancic et al.
[34] reported lower serum cholesterol in a sample of MD
patients with attempted suicide compared to MD patients
without attempted suicides. In a recent study, Troisi [35]
found that attentional impulsiveness (i.e., the inability to
focus attention or concentrate, related to executive function
deficits and reduced cognitive flexibility), a demonstrated
risk factor for suicide, was associated with lower cholesterol
levels.
Interestingly, there are some studies that found a low
serum cholesterol level especially in violent suicide attempts
[36–38]. Vevera et al. [39] found that patients with a violent
suicidal attempt had significantly lower cholesterol levels
than patients with nonviolent attempts and the control
subjects. They suggested that low levels of cholesterol may be
associated with increased tendency for impulsive behaviour
and aggression and contribute to a more violent pattern of
suicidal behaviour. Tripodianakis et al. [40] provided further
confirmation to this hypothesis and found lower serum
cholesterol in violent suicide attempters together with an
increased noradrenaline turnover in such subjects. Further
observations about relationships between impulsivity and
violent behaviour seem to bring other indirect evidence to
the connection between lower cholesterol levels and violent
suicide attempts [41, 42].
The observation of lower serum cholesterol levels asso-
ciated with violent suicide attempts seems also to pertain
to schizophrenia. In fact, Marcˇinko et al. [43] found
that schizophrenic patients with a violent suicidal attempt
showed significantly lower cholesterol levels and significantly
higher cortisol level than patients with nonviolent attempts
and control subjects. These findings can be indicative of
a more generalized involvement of lower cholesterol levels in
violent suicide also in other psychiatric disorders than MD.
In fact, concerning suicidality, similar results were found
in anorexia nervosa [44], panic disorder [45], dissociative
disorder [46], and borderline personality disorder [47].
It has also been demonstrated that lower cholesterol
levels were associated with lifetime suicide attempts [48].
This observation was confirmed by the finding of another
study that showed a moderate positive association between
cholesterol, triglycerides, body mass index (BMI), and sui-
cide attempts in subjects with depressive symptoms during
the past 12 months [49]
Moreover, it has been reported that lower HDL-C levels
(≤40mg/dL) were associated with an increased prevalence of
suicide attempts in women [50]. The finding of a lower HDL-
C level in suicide attempters was also confirmed in other
studies [51, 52]
Recently, it has been suggested that alexithymia (a per-
sonality style characterized by diﬃculty in identifying and
describing feelings together with concrete and poor intro-
spective thinking, frequently but not necessarily associated
with depressive symptoms) may be related with cholesterol
dysregulation and increased suicidality. In particular, alex-
ithymic individuals with MD and higher suicide risk may
show lower HDL-C [53] and higher triglyceride levels [54].
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3. Neurobiological Mechanism of
the Relationships between Cholesterol
and Suicidality
In 1992 Engelberg [55] presented a hypothesis linking
cholesterol and the serotonergic system. He hypothesized
that a reduced serum cholesterol level may be accompanied
by changes in viscosity and function of serotonin receptors
and transporters as well as by decreased serotonin precursors
that may cause an increase in suicide ideation. Maes et al.
[56] focused their attention on the phenotype of haptoglobin
connected with chromosome 16, where the gene encoding
lecithin-cholesterol acetyltransferase (LCAT)—the enzyme
catalyzing cholesterol esterification in the blood—is located.
The authors hypothesized that decreased concentration of
esterified cholesterol might be connected with the defect
of chromosome 16 that may increase susceptibility to
depression by changes in the viscosity of the cellular mem-
brane increasing the risk of aggressive and autoaggressive
behaviour.
As consequence of decreased lipid microviscosity in neu-
ral membranes, serotonin receptor exposure on the mem-
brane surface may be reduced, with an hypofunction of such
receptors. The serotonergic system is strongly recognized
as being linked to suicidality and impulsive and aggressive
behaviour as lower concentrations of 5-hydroxyindolacetic
acid (5-HIAA) in the cerebrospinal fluid (CSF) in suicides
and suicide attempters were found in several studies [57].
Jokinen et al. [52] found a significant positive correlation
between serum total cholesterol and level of CSF 5-HIAA in
suicide attempters that remained significant after correction
for age, gender, BMI, and comorbid substance abuse, even
if earlier studies did not find an association [58]. These
findings were more recently confirmed by Hibbeln et al.
[59] who evaluated TC and CSF 5-HIAA in 42 drug-
naı¨ve suicide attempters (with blood samples acquired and
lumbar punctures performed in a standardized manner in
a controlled study setting) and found a significant positive
correlation between serum total cholesterol and level of CSF
5-HIAA.
As suggested by Jokinen et al. [52], it is also possible that
the relationship between cholesterol and the serotonergic
system may be a two-way relationship, hypothesis corrob-
orated by the study of Fischer et al. [60] who found an
association between higher LDL levels and the long allele
coding for serotonin transporter gene in women.
4. Studies That Did Not Find an Association
between Cholesterol and Suicidality
However, especially during the last years, involvement of
serum cholesterol in pathogenesis of suicide was doubted on
the basis of some studies [61, 62]. For instance, results of a
retrospective study conducted on 213 psychiatric inpatients
(including 61 patients with aﬀective disorders) did not find
significant diﬀerences in the serum cholesterol levels between
patients who had and had not made a suicide attempt after
controlling for age or body mass index [63]. In a pro-
spective study on 92 inpatients with an MD episode at
admission, regardless of a significant reduction in depression
and suicidality scores, analyses of serum lipid concentrations
after 1 and 4 weeks of antidepressant treatment showed
no significant diﬀerences in lipid levels between patients
with and without a history of attempted suicide, even
if in patients who used a violent suicide method, there
was a trend for lower TC levels compared to those with
nonviolent attempt [64]. Further evidence on the lack-of-
association hypothesis was also provided by Huang [65]
who evaluated serum lipid profiles, during a 2-year period,
in 168 subjects (109 patients with MD and 59 healthy
controls) and found that, even if serum lipid profile changes
in patients with MD during acute phase were observed,
there were no significant diﬀerences of any kind in serum
lipid profiles between MD patients with or without suicide
attempts. The lack of association was also confirmed in
a sample of suicidal borderline personality disorder patients
who showed no serum cholesterol levels diﬀerences between
nonsuicidal patients and healthy controls [66]. Moreover,
Pompili et al. [67] reported that nearly lethal resuscitated
suicide attempters had no low serum levels of cholesterol
and triglycerides compared to patients who had not made
a recent suicide attempt.
More recently, de Leon et al. [68] evaluated 193 current
suicide attempters and found that low cholesterol levels
were not associated with increased suicide risk but with
a decreased risk in men. The lack-of-association hypothesis
was substantially confirmed also by Persons et al. [69].
More recently, D’Ambrosio et al. [70] did not find any
association between serum lipid levels and suicide in patients
with bipolar disorder.
5. Conclusions
The majority of the studies reviewed in the present paper
suggested an interesting relationship between cholesterol lev-
els and suicidality, even if a further elucidation of a possible
pathophysiological mechanism with regard to cholesterol
and suicidality is necessary in future studies. On the other
hand, especially during the last years, relationships between
serum cholesterol and suicidality were doubted on the basis
of some recent studies that have not found any correlation.
Although, to date, it is hard to draw a clear conclusion on
this topic, it is possible to argue, on the basis of precision of
measurements and experimental designs of reviewed studies,
that the accuracy of earlier studies, that is, those supporting
the hypothesis of a link between cholesterol levels and
suicide, was somewhat lower than more recent studies that
did not find any relationship. Moreover, it has been observed
that changes in plasma cholesterol may be shared by other
clinical entities, not clearly corresponding to a peculiarity
of suicidality. However, the debate on relationships between
cholesterol and suicide is open and longitudinal studies on
a larger sample of patients are needed to further clarify
this important issue, even if the time to get any conclusive
data using longitudinal designs in items such as suicide
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(among many others) may take longer than the lifespan of
the researcher.
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